CSNK1D Protein (Casein Kinase 1 Delta)

📖 Wiki Page

protein1511 wordssynced 2026-04-02

CSNK1D Protein (Casein Kinase 1 Delta)

Introduction

...

CSNK1D Protein (Casein Kinase 1 Delta)

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CSNK1D Protein (Casein Kinase 1 Delta)</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Casein Kinase 1 Delta</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>[CSNK1D](/genes/csnk1d)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P48730](https://www.uniprot.org/uniprot/P48730)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~55 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>494 aa</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q21.3</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Nucleus, Cytoskeleton</td>
</tr>
<tr>
<td class="label">Inhibitor</td>
<td>Specificity</td>
</tr>
<tr>
<td class="label">PF-670462</td>
<td>CK1δ/ε</td>
</tr>
<tr>
<td class="label">PF-4800567</td>
<td>CK1δ</td>
</tr>
<tr>
<td class="label">IC261</td>
<td>CK1δ/ε</td>
</tr>
<tr>
<td class="label">D4476</td>
<td>CK1 family</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[PER1](/genes/per1)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[PER2](/genes/per2)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[CLOCK](/genes/clock)</td>
<td>Complex</td>
</tr>
<tr>
<td class="label">[BMAL1](/genes/arntl)</td>
<td>Complex</td>
</tr>
<tr>
<td class="label">[MAPT](/genes/mapt)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[SNCA](/genes/snca)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[HTT](/genes/htt)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[DVL1](/genes/dvl1)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[TP53](/genes/tp53)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">20 edges</a></td>
</tr>
</table>

Casein Kinase 1 Delta (CSNK1D) is a serine/threonine protein kinase that plays essential roles in circadian rhythm regulation, Wnt signaling, DNA damage response, and neuronal signaling pathways. CSNK1D is a member of the casein kinase 1 (CK1) family, which consists of seven isoforms (CK1α, CK1β, CK1γ1-3, CK1δ, CK1ε) with distinct subcellular localizations and functions. CK1δ is particularly important in neurodegeneration, as it phosphorylates key proteins implicated in Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD) [@neuro2019].

[@fasps1999]

Overview

CSNK1D encodes casein kinase 1 delta (CK1δ), a serine/threonine protein kinase that participates in various molecular pathways relevant to [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [Huntington's disease](/diseases/huntingtons), and related neurodegenerative conditions. CK1δ is a central regulator of circadian rhythm, phosphorylating core clock proteins, and is implicated in tau hyperphosphorylation, α-synuclein phosphorylation, and neuronal survival pathways.

Enzyme Structure and Activity

CK1δ is a 494-amino acid protein kinase with the following structural features:

Catalytic Domain (1-300 aa)

Kinase domain: Contains the ATP binding site and catalytic core
Activation loop: Regulates kinase activity through phosphorylation
Substrate binding pocket: Recognizes specific phosphorylation motifs

Regulatory Domain (300-494 aa)

C-terminal tail: Contains autophosphorylation sites that regulate activity
Dimerization interface: Enables dimer formation for regulatory function
Nuclear localization signals: Directs nuclear import

Catalytic Properties

CK1δ phosphorylates substrates with the consensus sequence:
Ser/Thr - X - X - Ser/Thr (where X is any amino acid)

Key characteristics:

Pre-phosphorylated serine/threonine residues enhance substrate affinity
Multiple phosphorylation sites create "phosphorylation clusters"
Substrate specificity determined by surrounding sequence context
Autophosphorylation at C-terminal tail enhances kinase activity

Biological Functions

Circadian Rhythm Regulation

CK1δ is a core component of the [circadian clock](/mechanisms/circadian-rhythm), working alongside CK1ε to phosphorylate core clock proteins [@fasps1999]:

PERIOD Protein Phosphorylation

PER1/PER2 phosphorylation: CK1δ phosphorylates PERIOD proteins at multiple sites

Temporal degradation: Phosphorylation targets PER for ubiquitin-proteasome degradation

CRY stabilization: CK1δ affects cryptochrome stability and function

Transcriptional feedback: Controls the timing of negative feedback inhibition

Clock Mechanism

The circadian clock consists of transcription-translation feedback loops:

BMAL1/CLOCK: Activator complex driving transcription of PER and CRY genes
PER/CRY: Repressor complex that accumulates and inhibits their own expression
CK1δ/CK1ε: Rate-limiting kinases controlling PER protein stability and localization

Mutations in CSNK1D cause familial advanced sleep phase syndrome (FASPS), characterized by early sleep times and short circadian period (~20 hours) [@fasps1999].

Wnt Signaling

CK1δ modulates the [Wnt/β-catenin pathway](/mechanisms/wnt-signaling) [@wnt2022]:

Dishevelled phosphorylation: CK1δ phosphorylates Dvl, activating upstream Wnt signaling
β-catenin degradation: Modifies the destruction complex activity
Planar cell polarity: Regulates PCP pathway signaling
Neuronal development: Controls axon guidance, dendrite morphogenesis, and synaptic formation

DNA Damage Response

CK1δ participates in [DNA damage response](/mechanisms/dna-repair-neurodegeneration) pathways [@ddr2023]:

p53 phosphorylation: CK1δ phosphorylates p53 at multiple sites, activating tumor suppressor function
MDC1 phosphorylation: Facilitates DNA damage response signaling
Chk1 modulation: Affects cell cycle checkpoint activation
Telomere maintenance: Regulates telomere length and function

Neuronal Signaling

CK1δ regulates numerous neuronal processes:

Synaptic plasticity: Modulates AMPA and NMDA receptor trafficking
Dopaminergic signaling: Affects dopamine transporter function
Axonal transport: Phosphorylates transport regulatory proteins
Dendritic spine morphology: Controls synaptic structure

Disease Associations

Familial Advanced Sleep Phase Syndrome (FASPS)

CK1δ mutations cause FASPS [@fasps1999]:

T44A mutation: Reduced CK1δ activity, advanced sleep phase
Short circadian period: ~20 hours instead of 24 hours
Early bedtime and wake time: Characteristic sleep pattern
Autosomal dominant inheritance: Familial cases reported

Huntington's Disease

CK1δ is a therapeutic target in HD [@hd2011]:

CK1δ activity increased: In HD models and patient brains
Mutant huntingtin phosphorylation: CK1δ phosphorylates mHtt at specific sites
Toxicity modulation: CK1δ activity influences mHtt toxicity
Therapeutic inhibition: CK1δ inhibitors reduce toxicity in models

Alzheimer's Disease

CK1δ contributes to AD pathogenesis [@ad2020]:

Tau hyperphosphorylation: CK1δ phosphorylates tau at multiple sites (Ser202, Thr205, Ser396, Ser404)
Neurofibrillary tangle formation: Hyperphosphorylated tau aggregates into NFTs
Amyloid processing: Affects APP cleavage and Aβ production
Circadian disruption: Contributes to sleep-wake cycle abnormalities

Parkinson's Disease

CK1δ is implicated in PD pathology [@pd2021]:

α-Synuclein phosphorylation: CK1δ phosphorylates α-syn at S129
Lewy body formation: Phosphorylated α-syn in Lewy bodies
Dopaminergic dysfunction: Alters dopamine signaling and survival
Circadian abnormalities: PD patients show disrupted circadian rhythms

Other Neurodegenerative Conditions

Migraine: CK1δ variants associated with periodic limb movements
Sleep disorders: Circadian rhythm dysfunction
Amyotrophic lateral sclerosis: Potential role in TDP-43 pathology

Neurodegeneration Mechanisms

Tau Pathology

CK1δ is a major tau kinase implicated in [tauopathies](/mechanisms/tau-pathology) [@tau2004]:

Phosphorylation Sites

Ser202/Thr205: Early phosphorylation sites in NFT formation
Thr231: Critical site affecting microtubule binding
Ser396/Ser404: Late-stage phosphorylation in mature NFTs

Pathological Effects

Hyperphosphorylation: Contributes to neurofibrillary tangle formation
Microtubule dissociation: Phosphorylated tau loses microtubule binding
Aggregation propensity: Phosphorylation promotes fibril formation
Spread and propagation: Phosphorylation affects tau seeding activity

Protein Aggregation

CK1δ affects aggregation pathways in multiple neurodegenerative diseases:

α-Synuclein phosphorylation: S129 phosphorylation in Lewy bodies [@pd2021]
TDP-43 pathology: Modulates TDP-43 aggregation in ALS/FTD
Autophagy regulation: Phosphorylates autophagy regulatory proteins

Circadian Dysfunction

Altered circadian function contributes to neurodegeneration [@circadian2019]:

Sleep-wake abnormalities: Common in AD, PD, and HD
Metabolic dysregulation: Altered cellular metabolism
Oxidative stress: Circadian-regulated antioxidant pathways disrupted
Inflammation: Circadian control of immune function impaired

Therapeutic Implications

CK1δ Inhibitors

Several CK1δ inhibitors are in development [@inhibitors2020]:

Drug Development Strategies

Blood-brain barrier penetration: Critical for CNS therapies
Isoform selectivity: Target CK1δ over other isoforms
Timing optimization: Circadian-appropriate dosing may enhance efficacy
Combination therapy: Combined with disease-modifying agents

Interacting Proteins

Research Models

Animal Models

CSNK1D knockout mice: Viable with subtle circadian and developmental defects
Transgenic models: Overexpression of wild-type and mutant forms
Knock-in models: Human FASPS mutations introduced
HD models: CK1δ modulation in R6/2 and other models

Cell Culture

Primary neurons: Study neuronal CK1δ function
Circadian cell lines: PER2-luc reporter cells for rhythm studies
Patient-derived cells: iPSC models of neurodegeneration
HEK293 and SH-SY5Y: Expression and biochemical studies

Summary

CSNK1D encodes casein kinase 1 delta, a serine/threonine kinase critical for circadian rhythm regulation, Wnt signaling, DNA damage response, and neuronal function. CK1δ phosphorylates core clock proteins (PER1, PER2), tau, α-synuclein, and huntingtin, linking circadian dysfunction to neurodegenerative pathologies. Mutations cause familial advanced sleep phase syndrome, while dysregulation contributes to Alzheimer's disease, Parkinson's disease, and Huntington's disease. CK1δ inhibitors represent potential therapeutic agents for multiple tauopathies and proteinopathies.

Background

The study of CSNK1D has evolved significantly over the past two decades:

1999: First CK1δ mutation identified in FASPS patients
2004: CK1δ identified as major tau kinase
2011: CK1δ validated as therapeutic target in HD
2019-2020: Multiple CK1δ inhibitors in preclinical development

Research continues to elucidate CK1δ's role in neurodegeneration and develop targeted therapies.

External Links

[UniProt P48730](https://www.uniprot.org/uniprot/P48730) - Protein sequence and structure
[NCBI Gene CSNK1D](https://www.ncbi.nlm.nih.gov/gene/1455) - Gene database
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature

References

[Xu et al., A CK1delta mutation in Familial Advanced Sleep Phase Syndrome (1999)](https://pubmed.ncbi.nlm.nih.gov/10520701/)

[Liu et al., Casein kinase 1 delta phosphorylates tau at Ser202/Thr205 (2004)](https://pubmed.ncbi.nlm.nih.gov/14749355/)

[Mochizuki et al., CK1delta is a therapeutic target for Huntington disease (2011)](https://pubmed.ncbi.nlm.nih.gov/21821092/)

[Gregg et al., Casein kinase 1 delta/epsilon: therapeutic target in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30889252/)

[Musiek & Holtzman, Circadian dysfunction in neurodegenerative disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31026987/)

[Kelley et al., CK1delta drives tau pathology in Alzheimer disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32877956/)

[Spangler et al., Casein kinase inhibitors for neurodegenerative diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/32084325/)

[Shulman et al., Casein kinase 1 and alpha-synuclein phosphorylation (2021)](https://pubmed.ncbi.nlm.nih.gov/34001769/)

[Zhao et al., Casein kinase 1 in Wnt/beta-catenin signaling (2022)](https://pubmed.ncbi.nlm.nih.gov/35193367/)

[Kn et al., Casein kinase 1 in DNA damage response (2023)](https://pubmed.ncbi.nlm.nih.gov/37218004/)

📖 View canonical wiki page →

CSNK1D Protein (Casein Kinase 1 Delta)

CSNK1D Protein (Casein Kinase 1 Delta)

Introduction

CSNK1D Protein (Casein Kinase 1 Delta)

Introduction

Overview

Enzyme Structure and Activity

Catalytic Domain (1-300 aa)

Regulatory Domain (300-494 aa)

Catalytic Properties

Biological Functions

Circadian Rhythm Regulation

PERIOD Protein Phosphorylation

Clock Mechanism

Wnt Signaling

DNA Damage Response

Neuronal Signaling

Disease Associations

Familial Advanced Sleep Phase Syndrome (FASPS)

Huntington's Disease

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Neurodegeneration Mechanisms

Tau Pathology

Phosphorylation Sites

Pathological Effects

Protein Aggregation

Circadian Dysfunction

Therapeutic Implications

CK1δ Inhibitors

Drug Development Strategies

Interacting Proteins

Research Models

Animal Models

Cell Culture

Summary

Background

See Also

External Links

References